NCT07529535 2026-04-15A Phase I/II Study of ALK-N001 for Injection in Patients With Advanced Solid TumorsZhejiang Anglikang Pharmaceutical Co., Ltd.Phase 1 Suspended16 enrolled
NCT06388902 2025-11-21A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid MalignanciesBioRay Pharmaceutical Co., Ltd.Phase 1 Suspended120 enrolled